Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Motor Imagery and Functional Performance in Diplegic Cerebral Palsy

NCT07287215 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-11-24
Last updated
2025-12-17

Condition(s) studied

Diplegic Cerebral Palsy With SpasticityMotor İmagery Ability

Investigational drug(s) / intervention(s)

Motor Imagery Ability AssessmentMental Stopwatch ParadigmFunctional MobilityGait assessment:

Motor Imagery Ability Assessment: Laterality Task (Choice Task): Implicit Motor Imagery capacity will be measured through a laterality task, which involves deciding which side a limb belongs to. Right-left discrimination of the foot will be assessed using the "Recognize Foot" application developed by the Neuro Orthopaedic Institute

Mental Stopwatch Paradigm: A mental stopwatch will be used to assess explicit MI capacity. This paradigm compares the time between the actual movement duration and the duration of a similar imagined task.

Functional Mobility: Functional Mobility: Functional Mobility will be assessed using the Functional Mobility Scale (FMS) and the Timed Up and Go test.

Gait assessment:: Gait assessment: The Gillette FDA is a self- or observer-based assessment tool.

Study summary

The main purpose of this study was to examine the relationship between motor imagery capacity and functional mobility, walking and balance in children with diplegic type cerebral palsy.

Eligibility

Sex
ALL
Min age
5 Years
Max age
18 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Diagnosed with diplegic CP by a neurologist or pediatric neurologist * Being between 5 and 18 years of age * Being between levels I and III on the GMFCS * Having the cognitive ability to follow the assessment instructions * Informed consent form has been obtained from the child's family * The child has agreed to participate voluntarily in the study Exclusion Criteria: * Having severe impairments in basic sensory systems such as vision or hearing * Having additional diagnoses such as epilepsy or autism spectrum disorder * Demonstrating cognitive or behavioral problems that prevent them from following instructions during the assessment * Having informed consent from the child's family or the child

Primary outcome measure(s)

  • Mental Stopwatch Paradigm — 24-48 hours
    A mental stopwatch will be used to assess explicit MI capacity. This paradigm compares the time between the actual movement duration and the duration of a similar imagined task.
  • Laterality Task (Choice Task): — 24-48 hours
    Laterality Task (Choice Task): Implicit Motor Imagery capacity will be measured through a laterality task, which involves deciding which side a limb belongs to. Right-left discrimination of the foot will be assessed using the "Recognize Foot" application developed by the Neuro Orthopaedic Institute
  • Functional Mobility using the Functional Mobility Scale (FMS) — 24-48 hours
    Functional Mobility: Functional Mobility will be assessed using the Functional Mobility Scale (FMS)
  • Functional Mobility using the Timed Up and Go test — 24-48 hours
    Functional Mobility: Functional Mobility will be assessed using the Timed Up and Go test.
  • The Gillette Functional Assessment Questionnaire — 24-48 hours
    Gait assessment: The Gillette Functional Assessment Questionnaire is a self- or observer-based assessment tool, minimum score 22 maximum score 88

Trial sites (1)

FacilityCityRegionStatus
Bingöl Bingoel Turkey (Türkiye) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07287215 on ClinicalTrials.gov ↗ ← All trials in Turkey